Community-based misoprostol for the prevention of post-partum haemorrhage

A narrative review of the evidence base, challenges and scale-up

Karen Hobday, Jennifer Hulme, Suzanne Belton, Caroline SE Homer, Ndola Prata

    Research output: Contribution to journalArticleResearchpeer-review

    Abstract

    Achieving Sustainable Development Goal targets for 2030 will require persistent investment and creativity in improving access to quality health services, including skilled attendance at birth and access to emergency obstetric care. Community-based misoprostol has been extensively studied and recently endorsed by the WHO for the prevention of post-partum haemorrhage. There remains little consolidated information about experience with implementation and scale-up to date. This narrative review of the literature aimed to identify the political processes leading to WHO endorsement of misoprostol for the prevention of post-partum haemorrhage and describe ongoing challenges to the uptake and scale-up at both policy and community levels. We review the peer-reviewed and grey literature on expansion and scale-up and present the issues central to moving forward.

    Original languageEnglish
    Pages (from-to)1081-1097
    Number of pages17
    JournalGlobal Public Health
    Volume13
    Issue number8
    Early online date30 Mar 2017
    DOIs
    Publication statusPublished - 3 Aug 2018

    Fingerprint

    Misoprostol
    Hemorrhage
    Literature
    Peer Review
    Creativity
    Conservation of Natural Resources
    Emergency Medical Services
    Obstetrics
    Health Services
    Parturition

    Cite this

    Hobday, Karen ; Hulme, Jennifer ; Belton, Suzanne ; Homer, Caroline SE ; Prata, Ndola. / Community-based misoprostol for the prevention of post-partum haemorrhage : A narrative review of the evidence base, challenges and scale-up. In: Global Public Health. 2018 ; Vol. 13, No. 8. pp. 1081-1097.
    @article{b66b07b1d2cb436caabc07acd17626fe,
    title = "Community-based misoprostol for the prevention of post-partum haemorrhage: A narrative review of the evidence base, challenges and scale-up",
    abstract = "Achieving Sustainable Development Goal targets for 2030 will require persistent investment and creativity in improving access to quality health services, including skilled attendance at birth and access to emergency obstetric care. Community-based misoprostol has been extensively studied and recently endorsed by the WHO for the prevention of post-partum haemorrhage. There remains little consolidated information about experience with implementation and scale-up to date. This narrative review of the literature aimed to identify the political processes leading to WHO endorsement of misoprostol for the prevention of post-partum haemorrhage and describe ongoing challenges to the uptake and scale-up at both policy and community levels. We review the peer-reviewed and grey literature on expansion and scale-up and present the issues central to moving forward.",
    keywords = "advance distribution, community-based, Misoprostol, post-partum haemorrhage, scale-up",
    author = "Karen Hobday and Jennifer Hulme and Suzanne Belton and Homer, {Caroline SE} and Ndola Prata",
    year = "2018",
    month = "8",
    day = "3",
    doi = "10.1080/17441692.2017.1303743",
    language = "English",
    volume = "13",
    pages = "1081--1097",
    journal = "Global Public Health",
    issn = "1744-1692",
    publisher = "Routledge",
    number = "8",

    }

    Community-based misoprostol for the prevention of post-partum haemorrhage : A narrative review of the evidence base, challenges and scale-up. / Hobday, Karen; Hulme, Jennifer; Belton, Suzanne; Homer, Caroline SE; Prata, Ndola.

    In: Global Public Health, Vol. 13, No. 8, 03.08.2018, p. 1081-1097.

    Research output: Contribution to journalArticleResearchpeer-review

    TY - JOUR

    T1 - Community-based misoprostol for the prevention of post-partum haemorrhage

    T2 - A narrative review of the evidence base, challenges and scale-up

    AU - Hobday, Karen

    AU - Hulme, Jennifer

    AU - Belton, Suzanne

    AU - Homer, Caroline SE

    AU - Prata, Ndola

    PY - 2018/8/3

    Y1 - 2018/8/3

    N2 - Achieving Sustainable Development Goal targets for 2030 will require persistent investment and creativity in improving access to quality health services, including skilled attendance at birth and access to emergency obstetric care. Community-based misoprostol has been extensively studied and recently endorsed by the WHO for the prevention of post-partum haemorrhage. There remains little consolidated information about experience with implementation and scale-up to date. This narrative review of the literature aimed to identify the political processes leading to WHO endorsement of misoprostol for the prevention of post-partum haemorrhage and describe ongoing challenges to the uptake and scale-up at both policy and community levels. We review the peer-reviewed and grey literature on expansion and scale-up and present the issues central to moving forward.

    AB - Achieving Sustainable Development Goal targets for 2030 will require persistent investment and creativity in improving access to quality health services, including skilled attendance at birth and access to emergency obstetric care. Community-based misoprostol has been extensively studied and recently endorsed by the WHO for the prevention of post-partum haemorrhage. There remains little consolidated information about experience with implementation and scale-up to date. This narrative review of the literature aimed to identify the political processes leading to WHO endorsement of misoprostol for the prevention of post-partum haemorrhage and describe ongoing challenges to the uptake and scale-up at both policy and community levels. We review the peer-reviewed and grey literature on expansion and scale-up and present the issues central to moving forward.

    KW - advance distribution

    KW - community-based

    KW - Misoprostol

    KW - post-partum haemorrhage

    KW - scale-up

    UR - http://www.scopus.com/inward/record.url?scp=85016451875&partnerID=8YFLogxK

    U2 - 10.1080/17441692.2017.1303743

    DO - 10.1080/17441692.2017.1303743

    M3 - Article

    VL - 13

    SP - 1081

    EP - 1097

    JO - Global Public Health

    JF - Global Public Health

    SN - 1744-1692

    IS - 8

    ER -